Cargando…

How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?

The potential health and economic value of a vaccine for coronavirus disease (COVID-19) is self-evident given nearly 2 million deaths, “collateral” loss of life as other conditions go untreated, and massive economic damage. Results from the first licensed products are very encouraging; however, ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Towse, Adrian, Chalkidou, Kalipso, Firth, Isobel, Kettler, Hannah, Silverman, Rachel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. 2021
Materias:	Themed Section: COVID-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892302/ https://www.ncbi.nlm.nih.gov/pubmed/33933230 http://dx.doi.org/10.1016/j.jval.2020.12.008

Ejemplares similares

Using Contingent Valuation Method to Estimate Adults’ Willingness to Pay for a Future Coronavirus 2019 Vaccination
por: Vo, Nam Xuan, et al.
Publicado: (2021)

Heterologous COVID-19 Vaccination in Spain: A Case Study of Individual Autonomy in the Real World
por: Dal-Ré, Rafael, et al.
Publicado: (2022)

The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19)
por: Mullins, C. Daniel, et al.
Publicado: (2020)

Coronavirus Disease 2019 in 5 Neighboring Limited-Resource Countries: A Financial and Health Threat
por: Hussain, Yaseen, et al.
Publicado: (2021)

Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs
por: Manski, Charles F., et al.
Publicado: (2021)

How Expensive Are Hospitalizations by COVID-19? Evidence From Colombia
por: Alvis-Zakzuk, Nelson J., et al.
Publicado: (2022)

Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group
por: Leahy, Joy, et al.
Publicado: (2020)

The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease–2019 Treatments Available and Affordable
por: Forsythe, Steven, et al.
Publicado: (2020)

Real-World Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies During the COVID-19 Pandemic
por: Murteira, Rodrigo, et al.
Publicado: (2022)

Societal Effects Are a Major Factor for the Uptake of the Coronavirus Disease 2019 (COVID-19) Digital Contact Tracing App in The Netherlands
por: Mouter, Niek, et al.
Publicado: (2021)

The Effects of Severe Acute Respiratory Syndrome Coronavirus 2 on the Reported Mental Health Symptoms of Nonprofessional Carers: An Analysis Across Europe
por: Peña-Longobardo, Luz María, et al.
Publicado: (2022)

Minimizing Population Health Loss in Times of Scarce Surgical Capacity During the Coronavirus Disease 2019 Crisis and Beyond: A Modeling Study
por: Gravesteijn, Benjamin, et al.
Publicado: (2021)

Will Americans Get Vaccinated? Predicting COVID-19 Vaccine Uptake Rates Under Contingent Scenarios
por: Vásquez, William F., et al.
Publicado: (2021)

Cost Utility of Vaccination Against COVID-19 in Brazil
por: Fernandes, Ricardo Ribeiro Alves, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Strategies of COVID-19 Vaccination in Colombia: Comparison of High-Risk Prioritization and No Prioritization Strategies With the Absence of a Vaccination Plan
por: Morales-Zamora, Gilberto, et al.
Publicado: (2022)

Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review
por: Lau, Oscar, et al.
Publicado: (2022)

Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: A Discrete Choice Experiment in The Netherlands
por: Mouter, Niek, et al.
Publicado: (2022)

Measuring “Fearonomic Effects” in Valuing Therapies: An Application to COVID-19 in China
por: Ma, Siyu, et al.
Publicado: (2020)

Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations
por: Dawoud, Dalia M., et al.
Publicado: (2020)

Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study
por: Reed, Shelby, et al.
Publicado: (2020)

Costing the COVID-19 Pandemic: An Exploratory Economic Evaluation of Hypothetical Suppression Policy in the United Kingdom
por: Zala, Darshan, et al.
Publicado: (2020)

Facing the Threat of COVID-19 in Pakistan: A Nation’s Dilemma
por: Habib, Murad, et al.
Publicado: (2021)

Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies
por: Zhao, Jidi, et al.
Publicado: (2021)

Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis
por: Shlomai, Amir, et al.
Publicado: (2021)

Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States
por: Basu, Anirban, et al.
Publicado: (2021)

Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review
por: Vandepitte, Sophie, et al.
Publicado: (2021)

Predicting Hospital Resource Use During COVID-19 Surges: A Simple but Flexible Discretely Integrated Condition Event Simulation of Individual Patient-Hospital Trajectories
por: Caro, J. Jaime, et al.
Publicado: (2021)

Evidence of Stability in Patient-Reported Global Health During the COVID-19 Pandemic
por: Lapin, Brittany R., et al.
Publicado: (2021)

Family Caregivers’ Experiences and Changes in Caregiving Tasks During the COVID-19 Pandemic
por: Irani, Elliane, et al.
Publicado: (2021)

Quality-Adjusted Life-Years Lost Due to COVID-19 Mortality: Methods and Application for The Netherlands
por: Wouterse, Bram, et al.
Publicado: (2022)

The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19
por: Whittington, Melanie D., et al.
Publicado: (2022)

A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales
por: Rafia, Rachid, et al.
Publicado: (2022)

Diagnostics and Treatments of COVID-19: A Living Systematic Review of Economic Evaluations
por: Elvidge, Jamie, et al.
Publicado: (2022)

Healthcare Resource Utilization of Patients With COVID-19 Visiting US Hospitals
por: Moon, Rena C., et al.
Publicado: (2022)

Quantifying the Effect of Public Activity Intervention Policies on COVID-19 Pandemic Containment Using Epidemiologic Data From 145 Countries
por: Sun, Jichao, et al.
Publicado: (2022)

COVID-19 Health Economics: Looking Back and Scoping the Future
por: Postma, Maarten J., et al.
Publicado: (2022)

“Bring the Hoses to Where the Fire Is!”: Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs
por: Cheung, Douglas C., et al.
Publicado: (2022)

Americans’ Health Priorities During the COVID-19 Pandemic
por: Cook, Joseph, et al.
Publicado: (2022)

Brief Cost Analysis of Surgical Personal Protective Equipment During the COVID-19 Pandemic
por: Kapinos, Kandice A., et al.
Publicado: (2022)

A Systematic Review of Economic Evaluations of COVID-19 Interventions: Considerations of Non-Health Impacts and Distributional Issues
por: Podolsky, Meghan I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mpe4030u11kcig6bh4jho15n9j